MSAC gap may hit PBAC five

By Megan Brodie 3 years ago | In Companies, Products, Regulatory
  • 3 years ago

6 September 2021 Merck’s new targeted lung cancer drug TEPMETKO (tepotinib) is one of five…

This is subscriber-only content. Please login to continue reading.